2025 Speaker Faculty Included:

Alan Watt, President & Chief Scientific Officer - 7th Inflammasome Therapeutics Summit

Alan Watt

President & Chief Scientific Officer

NodThera Ltd.

Brian Levy, Chief Executive Officer - 7th Inflammasome Therapeutics Summit

Brian Levy

Chief Executive Officer

InflammX Therapeutics

Cynthia Lebeaupin, Senior Scientist, Inflammation & Immunology -7th Inflammasome Therapeutics Summit

Cynthia Lebeaupin

Senior Scientist, Inflammation & Immunology R&D

Pfizer

Denisa Wagner, Professor, Pediatrics - 7th Inflammasome Therapeutics Summit

Denisa Wagner

Professor, Pediatrics

Harvard Medical School

Elad Elkayam, Principal Investigator - 7th Inflammasome Therapeutics Summit

Elad Elkayam

Principal Investigator

Ventus Therapeutics

Elliott Gruskin, Chief Executive Officer - 7th Inflammasome Therapeutics Summit

Elliott Gruskin

Chief Executive Officer

Azome Therapeutics

Hal Hoffmanm, Professor, Pediatrics & Medicine - 7th Inflammasome Therapeutics Summit

Hal Hoffman

Professor, Pediatrics & Medicine

University of California, San Diego

John Nuss, Chief Scientific Officer - 7th Inflammasome Therapeutics Summit

John Nuss

CSO

Ventyx Biosciences

Juan Pablo de Rivero Vaccari, Miller School of Medicine - 7th Inflammasome Therapeutics Summit

Juan Pablo de Rivero Vaccari

Associate Professor - Neurological Surgery, Neuroscience Graduate Program Faculty, Cellular Physiology & Molecular Biophysics G

University of Miami School of Medicine

Kiran Bhaskar, TheraVac Biologics -7th Inflammasome Therapeutics Summit

Kiran Bhaskar

Scientific Co-Founder

TheraVac Biologics

Lauren Martens, Vice President - Biology - 7th Inflammasome Therapeutics Summit

Lauren Martens

Vice President, Biology

Neumora Therapeutics, Inc.

Marc Pelletier, Novartis - 7th Inflammasome Therapeutics Summit

Marc Pelletier

Translational Immune Oncology, Associate Director

Novartis AG

Nick Brandon

Chief Scientific Officer

Neumora Therapeutics, Inc.

Olaf Groß, Professor, Principal Investigator - 7th Inflammasome Therapeutics Summit

Olaf Groß

Professor, Principal Investigator

University Medical Center Freiburg

Paul Ashton, Inflammasome Therapeutics - 7th Inflammasome Therapeutics Summit

Paul Ashton

Chief Executive Officer

Inflammasome Therapeutics

Rashmin Savani, Head, Scientific Advisory Board - 7th Inflammasome Therapeutics Summit

Rashmin Savani

Head, Scientific Advisory Board

Azome Therapeutics

Roberto De Luca, Beth Israel Deaconess Medical Center - 7th Inflammasome Therapeutics Summit

Roberto De Luca

Instructor of Neurology

Beth Israel Deaconess Medical Center (Harvard Medical School)

Roberto Negro, Senior Scientist - 7th Inflammasome Therapeutics Summit

Roberto Negro

Senior Scientist

National Institute of gastroenterology S. de Bellis

Shawn Seong - 7th Inflammasome Therapeutics Summit

Shawn Seong

Chief Executive Officer

Shaperon

Shidong Wang

Senior Regional Business Manager

Alamar Biosciences Inc.

2025 Full Event Guide
Partner
Register Interest